Tzu Chi Medical Journal
Volume 22, Issue 2 , Pages 90-95 , June 2010

Effect of Intravenous N-acetylcysteine on Plasma Total Homocysteine and Inflammatory Cytokines During High Flux Hemodialysis

  • Jen-Pi Tsai

      Affiliations

    • Department of Nephrology, Buddhist Dalin Tzu Chi General Hospital, Chiayi, Taiwan
    • ,
  • Fwu-Lin Yang

      Affiliations

    • Surgical Critical Care Unit, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
    • School of Medicine, Tzu Chi University, Hualien, Taiwan
    • ,
  • Chih-Hsien Wang

      Affiliations

    • Department of Nephrology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • School of Medicine, Tzu Chi University, Hualien, Taiwan
    • ,
  • Te-Chao Fang

      Affiliations

    • Department of Nephrology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • School of Medicine, Tzu Chi University, Hualien, Taiwan
    • ,
  • Ru-Ping Lee

      Affiliations

    • Department of Nursing, Tzu Chi University, Hualien, Taiwan
    • ,
  • Bang-Gee Hsu

      Affiliations

    • Department of Nephrology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • School of Medicine, Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Nephrology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Received 2 September 2009 ,Revised 22 September 2009 ,Accepted 10 June 2010.

References 

  1. Harnett JD , Foley RN , Kent GM , Barre PE , Murray D , Parfrey PS . Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors . Kidney Int . 1995;47:884–890
  2. Stenvinkel P , Alvestrand P . Inflammation in end-stage renal disease: sources, consequences and therapy . Semin Dial . 2002;15:330–338
  3. Kennedy R , Case C , Fathi R , Johnson D , Isbel N , Marwick TH . Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? . Am J Med . 2001;110:198–204
  4. Kalantar-Zadeh K , Ikizler TA , Block G , Avram MM , Kopple JD . Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences . Am J Kidney Dis . 2003;42:864–881
  5. Arici M , Walls J . End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? . Kidney Int . 2001;59:407–414
  6. Stenvinkel P , Ketteler M , Johnson RJ , et al.   IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly . Kidney Int . 2005;67:1216–1233
  7. Rubin C , Nolin TD , Himmelfarb J . Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease? . Curr Opin Nephrol Hypertens . 2007;16:506–511
  8. Hsu BG , Yang FL , Lee RP , Peng TC , Harn HJ , Chen HI . N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats . J Biomed Sci . 2004;11:152–162
  9. Hsu BG , Lee RP , Yang FL , Harn HJ , Chen HI . Post-treatment with N-acetylcysteine ameliorates the endotoxin shockinduced organ damage in conscious rats . Life Sci . 2006;79:2010–2016
  10. Ventura P , Panini R , Pasini MC , Scarpetta G , Salvioli G . N-acetylcysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion . Pharmacol Res . 1999;40:345–350
  11. Wang JH , Subeq YM , Tsai WC , Lee RP , Hsu BG . Intravenous N-acetylcysteine improves renal function and ameliorates plasma total homocysteine in patients undergoing cardiac angiography . Ren Fail . 2008;30:527–533
  12. Thaha M , Yogiantoro M , Tomino Y . Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease . Clin Drug Investig . 2006;26:195–202
  13. Scholze A , Rinder C , Beige J , Riezler R , Zidek W , Tepel M . Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure . Circulation . 2004;109:369–374
  14. Lee CC , Lee RP , Subeq YM , Wang CH , Fang TC , Hsu BG . Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients . Arch Med Res . 2008;39:785–790
  15. Himmelfarb J , Stenvinkel P , Ikizler TA , Hakim RM . The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia . Kidney Int . 2002;62:1524–1538
  16. Himmelfarb J , Hakim RM . Oxidative stress in uremia . Curr Opin Nephrol Hypertens . 2003;12:593–598
  17. Witko-Sarsat V , Gausson V , Nguyen AT , et al.   AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients . Kidney Int . 2003;64:82–91
  18. Perna AF , Acanfora F , Satta E , Lombardi C , Ingrosso D , De Santo NG . Hyperhomocysteinemia and cardiovascular disease in uremia: the newest evidence in epidemiology and mechanisms of action . Semin Nephrol . 2004;24:426–430
  19. Mallamaci F , Zoccali C , Tripepi G , et al.   Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients . Kidney Int . 2002;61:609–614
  20. Ducloux D , Klein A , Kazory A , Devillard N , Chalopin JM . Impact of malnutrition-inflammation on the association between homocysteine and mortality . Kidney Int . 2006;69:331–335
  21. Jamison RL , Hartigan P , Kaufman JS , et al.   Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial . JAMA . 2007;298:1163–1170
  22. Perna AF , Luciano MG , Pulzella P , et al.   Is homocysteine toxic in uremia? . J Ren Nutr . 2008;18:12–17
  23. Friedman AN , Bostom AG , Laliberty P , Selhub J , Shemin D . The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study . Am J Kidney Dis . 2003;41:442–446
  24. Ventura P , Panini R , Abbati G , Marchetti G , Salvioli G . Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy . Pharmacology . 2003;68:105–114
  25. De Vriese AS , Langlois M , Bernard D , et al.   Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients . Nephrol Dial Transplant . 2003;18:2596–2600

PII: S1016-3190(10)60047-X

doi: 10.1016/S1016-3190(10)60047-X

Tzu Chi Medical Journal
Volume 22, Issue 2 , Pages 90-95 , June 2010

Article Tools